Related Experiment Video
Updated: Aug 22, 2025

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
Published on: March 21, 2021
Lung involvement in children with COVID-19 multisystem inflammatory syndrome
Michele Ghezzi1, Emma Longoni2, Alice Munari3
1Allergology and Pneumology Unit, V. Buzzi Children's Hospital, Milan, Italy.
This study evaluates lung involvement in children with multisystem inflammatory syndrome (MIS-C) using imaging and structured light plethysmography. Findings assess pulmonary function changes over time in MIS-C patients.
Area of Science:
- Pediatric critical care medicine
- Infectious diseases
- Pulmonology
Background:
- Multisystem inflammatory syndrome in children (MIS-C) is a post-infectious complication of COVID-19, often presenting with cardiac involvement.
- Pulmonary function data and detailed lung imaging findings in MIS-C patients are scarce.
- Structured light plethysmography (SLP) offers a non-contact method for assessing lung function, crucial during the COVID-19 pandemic.
Discussion:
- This study pioneers the use of SLP to evaluate lung function in children with MIS-C.
- It investigates lung involvement through imaging and functional assessment at admission and follow-up.
- The research addresses a critical gap in understanding the respiratory sequelae of MIS-C.
Key Insights:
- Initial lung involvement in MIS-C can be assessed via imaging and SLP.
- Pulmonary function is evaluated at hospital admission and 6 months post-admission.
- SLP provides a safe and effective alternative to spirometry for MIS-C lung function assessment.
Outlook:
- Further research should explore the long-term respiratory outcomes in MIS-C survivors.
- Understanding lung involvement can inform clinical management and therapeutic strategies for MIS-C.
- This study establishes a baseline for future investigations into pediatric post-infectious inflammatory syndromes.
Related Concept Videos
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology
Pulmonary Cycle: Exhalation
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis III: Medical Management
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:

